Award
National Cancer Institute RFA-CA-19-007
The Johns Hopkins Translational Science Team and Consortium for ETCTN Studies
Recipient
Johns Hopkins University
Award Amount
$1,817,609.00
Ceiling
$1,817,609.00
Awarded
February 28, 2025
Identifier
RFA-CA-19-007
Johns Hopkins University leads a consortium to conduct clinical trials on novel anticancer agents, with a focus on trial support, biological studies, and investigator training.
Description
A consortium led by Johns Hopkins University to support and conduct high-quality clinical trials evaluating novel anticancer agents, including supporting trials from Phase 1 to proof-of-activity, engaging investigators, implementing biological studies, and training new investigators.